Studies have shown that PD-L1-transduced tumor cells suppress immune resistance and that the removal of NK cells abrogates antitumor efficacy of PD-1 blockade, indicating that NK cells are responders to checkpoint blockade [24, 25]. Here, PDCD1 is linked to neoplasm.